Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03625011
Other study ID # IRB 18-052
Secondary ID
Status Recruiting
Phase Phase 4
First received
Last updated
Start date July 31, 2018
Est. completion date December 31, 2019

Study information

Verified date July 2019
Source Children's Healthcare of Atlanta
Contact Beena Desai
Phone 404-785-2269
Email beena.desai@choa.org
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this pilot study: 1) to examine the use of gabapentin in reducing pain in the first 48 hours postoperatively including the total amount of narcotics mg/kg given 2) to record the time to first analgesic postoperatively and 3) to compare Wong Baker and the 0-10 numeric pain distress scale scores at 12, 24 and 48 hours postoperatively. We hypothesize one 15mg/kg (up to 600mg) dose of gabapentin will decrease mean narcotic amounts in mg/kg compared to participants who do not receive preoperative gabapentin and will demonstrate a decreased mean time to first analgesic as well as to lower mean pain scores for each age group at 12, 24 and 48 hours.


Description:

This double blinded randomized control trial will enroll 50 children age 3-18 years, undergoing T/As from a regional healthcare organization. Patients will be receiving either one gabapentin dose (15mg/kg up to 600mg) or placebo preoperatively. Both control and test group will receive the standard narcotic regimen intraoperatively. Additionally, young children will receive instruction for Tylenol and Motrin postoperatively while teenagers will receive a narcotic prescription. Outcome measurements include: mean Tylenol mg/kg, Motrin mg/kg and narcotic mg/kg use. Additional measurements: Mean time to first analgesic. Phone interviews with the research nurse for three days postoperatively will elicit pain scores at 12, 24 and 48 hours postoperatively.


Recruitment information / eligibility

Status Recruiting
Enrollment 50
Est. completion date December 31, 2019
Est. primary completion date December 31, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 3 Years to 18 Years
Eligibility Inclusion Criteria:

- participants age 3-18 years

- ASA class 1 or 2

- elective Tonsillectomy/Adenoidectomy

- outpatient setting.

Exclusion Criteria:

- BMI >40kg/m2

- history of renal insufficiency, chronic pain

- allergy to gabapentin

- history of developmental delay

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
Gabapentin
This double blinded randomized control trial will enroll 50 children age 3-18 years, undergoing T/As. Patients will be receiving either one gabapentin dose (15mg/kg up to 600mg) or placebo preoperatively. Both control and test group will receive the standard narcotic regimen intraoperatively.

Locations

Country Name City State
United States Children's Healthcare of Atlanta Atlanta Georgia

Sponsors (1)

Lead Sponsor Collaborator
Children's Healthcare of Atlanta

Country where clinical trial is conducted

United States, 

References & Publications (7)

Amani S, Abedinzadeh MR. Effects of Oral Gabapentin, Local Bupivacaine and Intravenous Pethidine on Post Tonsillectomy Pain. Iran J Otorhinolaryngol. 2015 Sep;27(82):343-8. — View Citation

Amin SM, Amr YM. Comparison between preemptive gabapentin and paracetamol for pain control after adenotonsillectomy in children. Anesth Essays Res. 2011 Jul-Dec;5(2):167-70. doi: 10.4103/0259-1162.94758. — View Citation

Amin SM. Evaluation of gabapentin and dexamethasone alone or in combination for pain control after adenotonsillectomy in children. Saudi J Anaesth. 2014 Jul;8(3):317-22. doi: 10.4103/1658-354X.136417. Retraction in: Saudi J Anaesth. 2018 Oct-Dec;12(4):662. — View Citation

Hwang SH, Park IJ, Cho YJ, Jeong YM, Kang JM. The efficacy of gabapentin/pregabalin in improving pain after tonsillectomy: A meta-analysis. Laryngoscope. 2016 Feb;126(2):357-66. doi: 10.1002/lary.25636. Epub 2015 Sep 25. Review. — View Citation

Knipper E, Banta-Green CJ, Jimenez N. Opioid use disorder and misuse: A review of the epidemiology and medical implications for pediatric anesthesiologists. Paediatr Anaesth. 2017 Nov;27(11):1070-1076. doi: 10.1111/pan.13225. Review. — View Citation

Mohamed, M.H., Al-Sercy, H. (2014). Preoperative gabapentin decreases the incidence of postoperative vomiting and analgesic requirements after pediatric adenotonsillectomy. The Egyptian Journal of Otolaryngology. 225-228.

Thiels CA, Anderson SS, Ubl DS, Hanson KT, Bergquist WJ, Gray RJ, Gazelka HM, Cima RR, Habermann EB. Wide Variation and Overprescription of Opioids After Elective Surgery. Ann Surg. 2017 Oct;266(4):564-573. doi: 10.1097/SLA.0000000000002365. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Narcotic Consumption To examine the use of gabapentin in reducing pain in the first 48 hours postoperatively including the total amount of narcotics mg/kg(weight and height will be combined to report BMI in kg/m^2). First 48 hours postoperatively
Secondary First Analgesic Timing To record the time to first analgesic postoperatively First 48 Hours postoperatively
Secondary Pain Scale Scores To compare the Wong- Baker FACES Pain Rating Scale and the 1-10 numeric pain distress scale pain scores at 12, 24 and 48 hours postoperatively. The 0-10 Numeric Pain Distress Pain Scale utilizes number gradations to describe pain for school age children and adolescents. A zero score means the absence of pain while a five describes distressing pain and a ten infers unbearable pain. As for the Wong-Baker FACES Scale, a series of faces can be shown to children over the age of three. The six faces depict facial expressions with zero-no hurt at all, one-hurts just a little bit, two-hurts a little more, three-hurts even more, four-hurts a whole lot, and five- hurts as much as you can imagine. No subscales will be used or combined. 12, 24 and 48 hours postoperatively.
See also
  Status Clinical Trial Phase
Completed NCT03266094 - A Study of BiZactâ„¢ on Children and Adolescents Undergoing Tonsillectomy N/A
Completed NCT02228135 - The Effect of Dexamethasone Dosing on Post-tonsillectomy Hemorrhage N/A
Completed NCT00662987 - Effect of Duration of Antibiotic Therapy on Recovery Following Tonsillectomy N/A
Completed NCT00273754 - The Effect of Caffeine on Postextubation Adverse Respiratory Events in Children With Obstructive Sleep Apnea (OSA). Phase 2
Recruiting NCT06122948 - Effect of Intranasal Midazolam Versus Ketamine Midazolam Combination as a Premedication on the Occurrence of Postoperative Respiratory Adverse Events Phase 3
Recruiting NCT03783182 - Betamethasone (Betapred®) as Premedication for Reducing Postoperative Vomiting and Pain After Tonsillectomy Phase 4
Completed NCT03793816 - Tonsillectomy Using BiZactâ„¢ - a Randomized Side-controlled Clinical Trial N/A
Not yet recruiting NCT06359925 - Suprazygomatic Nerve Block in Tonsillectomy Patients N/A
Recruiting NCT06079125 - PFDD Versus PFDRT in Chiari Decompression Surgery N/A
Recruiting NCT01904461 - HemORL: Monocentric, Prospective, Comparative Study on the Use of a Haemostatic Vacuum Device During Tonsillectomy in Children N/A
Not yet recruiting NCT00756873 - Etoricoxib in Ear Nose Throat Surgery Phase 3
Recruiting NCT05600595 - The Evaluation of Eustachian Tube Function and Its Influencing Factors After Snoring Operation in Children
Completed NCT02987985 - Efficacy of Opioid-free Anesthesia in Reducing Postoperative Respiratory Depression in Children Undergoing Tonsillectomy Phase 3
Completed NCT04066829 - Default Dosing Settings for Opioid Prescriptions to Adolescents and Young Adults After Tonsillectomy N/A
Recruiting NCT05158348 - A Comparative Study to Measure the Effect of Nebulized Dexmedetomidine Phase 3
Completed NCT01605903 - Postoperative Ibuprofen and the Risk of Bleeding After Tonsillectomy With or Without Adenoidectomy Phase 2
Enrolling by invitation NCT02444533 - EXPAREL® for Pain After Tonsillectomy Phase 4
Recruiting NCT02829515 - Tonsil Surgery in Sweden: A National Quality Register
Not yet recruiting NCT03491085 - Role of Antibiotics Post Tonsillectomy Phase 1/Phase 2
Recruiting NCT05270109 - Cold Steel Versus "Hot" BiZact Tonsillectomy; Comparing Post Tonsillectomy Morbidity N/A